25 XP   0   0   10

Lyka Labs Limited
Buy, Hold or Sell?

Let's analyse Lyka Labs Limited together

PenkeI guess you are interested in Lyka Labs Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lyka Labs Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lyka Labs Limited

I send you an email if I find something interesting about Lyka Labs Limited.

Quick analysis of Lyka Labs Limited (30 sec.)










What can you expect buying and holding a share of Lyka Labs Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR13.80
Expected worth in 1 year
INR52.70
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
INR38.90
Return On Investment
30.2%

For what price can you sell your share?

Current Price per Share
INR128.80
Expected price per share
INR105.75 - INR152.95
How sure are you?
50%

1. Valuation of Lyka Labs Limited (5 min.)




Live pricePrice per Share (EOD)

INR128.80

Intrinsic Value Per Share

INR23.87 - INR72.03

Total Value Per Share

INR37.67 - INR85.84

2. Growth of Lyka Labs Limited (5 min.)




Is Lyka Labs Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$5.4m$1.6m$3.8m70.5%

How much money is Lyka Labs Limited making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m$4.6m-$6.2m-396.5%
Net Profit Margin-14.1%21.2%--

How much money comes from the company's main activities?

3. Financial Health of Lyka Labs Limited (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#746 / 1016

Most Revenue
#294 / 1016

Most Profit
#276 / 1016

Most Efficient
#488 / 1016

What can you expect buying and holding a share of Lyka Labs Limited? (5 min.)

Welcome investor! Lyka Labs Limited's management wants to use your money to grow the business. In return you get a share of Lyka Labs Limited.

What can you expect buying and holding a share of Lyka Labs Limited?

First you should know what it really means to hold a share of Lyka Labs Limited. And how you can make/lose money.

Speculation

The Price per Share of Lyka Labs Limited is INR128.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lyka Labs Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lyka Labs Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR13.80. Based on the TTM, the Book Value Change Per Share is INR9.72 per quarter. Based on the YOY, the Book Value Change Per Share is INR11.66 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lyka Labs Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.050.0%-0.050.0%0.140.1%-0.040.0%-0.030.0%
Usd Book Value Change Per Share0.120.1%0.120.1%0.140.1%-0.010.0%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.120.1%0.120.1%0.140.1%-0.010.0%-0.010.0%
Usd Price Per Share1.25-1.25-1.62-0.73-0.65-
Price to Earnings Ratio-26.14--26.14-11.52--7.35--4.53-
Price-to-Total Gains Ratio10.73-10.73-11.61-1.33--21.25-
Price to Book Ratio7.56-7.56-33.21-7.27-5.32-
Price-to-Total Gains Ratio10.73-10.73-11.61-1.33--21.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.5456
Number of shares646
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.12-0.01
Usd Total Gains Per Share0.12-0.01
Gains per Quarter (646 shares)75.39-5.89
Gains per Year (646 shares)301.55-23.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103022920-24-34
206035940-47-58
309058960-71-82
40120611980-94-106
50150815000-118-130
60180918020-141-154
70211121040-165-178
80241224060-188-202
90271427080-212-226
100301630100-235-250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%3.09.00.025.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%4.08.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%4.08.00.033.3%

Fundamentals of Lyka Labs Limited

About Lyka Labs Limited

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-01 10:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lyka Labs Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lyka Labs Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • A Net Profit Margin of -14.1% means that ₹-0.14 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lyka Labs Limited:

  • The MRQ is -14.1%. The company is making a huge loss. -2
  • The TTM is -14.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.1%TTM-14.1%0.0%
TTM-14.1%YOY21.2%-35.4%
TTM-14.1%5Y-26.2%+12.0%
5Y-26.2%10Y-17.1%-9.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.1%-197.2%+183.1%
TTM-14.1%-210.4%+196.3%
YOY21.2%-279.3%+300.5%
5Y-26.2%-436.8%+410.6%
10Y-17.1%-599.3%+582.2%
1.1.2. Return on Assets

Shows how efficient Lyka Labs Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • -8.7% Return on Assets means that Lyka Labs Limited generated ₹-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lyka Labs Limited:

  • The MRQ is -8.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.7%TTM-8.7%0.0%
TTM-8.7%YOY21.0%-29.7%
TTM-8.7%5Y-5.4%-3.2%
5Y-5.4%10Y-3.9%-1.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.7%-13.6%+4.9%
TTM-8.7%-12.9%+4.2%
YOY21.0%-11.9%+32.9%
5Y-5.4%-14.2%+8.8%
10Y-3.9%-16.2%+12.3%
1.1.3. Return on Equity

Shows how efficient Lyka Labs Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • -28.9% Return on Equity means Lyka Labs Limited generated ₹-0.29 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lyka Labs Limited:

  • The MRQ is -28.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.9%TTM-28.9%0.0%
TTM-28.9%YOY292.4%-321.3%
TTM-28.9%5Y49.9%-78.8%
5Y49.9%10Y18.9%+31.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.9%-17.0%-11.9%
TTM-28.9%-16.1%-12.8%
YOY292.4%-15.4%+307.8%
5Y49.9%-20.0%+69.9%
10Y18.9%-21.1%+40.0%

1.2. Operating Efficiency of Lyka Labs Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lyka Labs Limited is operating .

  • Measures how much profit Lyka Labs Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • An Operating Margin of 6.2% means the company generated ₹0.06  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lyka Labs Limited:

  • The MRQ is 6.2%. The company is operating less efficient.
  • The TTM is 6.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.2%TTM6.2%0.0%
TTM6.2%YOY46.4%-40.2%
TTM6.2%5Y6.5%-0.3%
5Y6.5%10Y4.1%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2%-286.1%+292.3%
TTM6.2%-224.4%+230.6%
YOY46.4%-288.4%+334.8%
5Y6.5%-475.2%+481.7%
10Y4.1%-624.7%+628.8%
1.2.2. Operating Ratio

Measures how efficient Lyka Labs Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are ₹0.97 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Lyka Labs Limited:

  • The MRQ is 0.974. The company is less efficient in keeping operating costs low.
  • The TTM is 0.974. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.974TTM0.9740.000
TTM0.974YOY0.547+0.427
TTM0.9745Y0.959+0.015
5Y0.95910Y1.056-0.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9742.997-2.023
TTM0.9743.247-2.273
YOY0.5473.766-3.219
5Y0.9595.675-4.716
10Y1.0567.857-6.801

1.3. Liquidity of Lyka Labs Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lyka Labs Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.36 means the company has ₹1.36 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Lyka Labs Limited:

  • The MRQ is 1.356. The company is just able to pay all its short-term debts.
  • The TTM is 1.356. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.356TTM1.3560.000
TTM1.356YOY0.525+0.831
TTM1.3565Y0.683+0.673
5Y0.68310Y0.569+0.114
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3563.930-2.574
TTM1.3564.251-2.895
YOY0.5255.436-4.911
5Y0.6836.045-5.362
10Y0.5696.363-5.794
1.3.2. Quick Ratio

Measures if Lyka Labs Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • A Quick Ratio of 1.14 means the company can pay off ₹1.14 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lyka Labs Limited:

  • The MRQ is 1.136. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.136. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.136TTM1.1360.000
TTM1.136YOY0.445+0.692
TTM1.1365Y0.557+0.579
5Y0.55710Y0.412+0.145
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1363.629-2.493
TTM1.1364.065-2.929
YOY0.4455.397-4.952
5Y0.5575.993-5.436
10Y0.4126.277-5.865

1.4. Solvency of Lyka Labs Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lyka Labs Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lyka Labs Limited to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.70 means that Lyka Labs Limited assets are financed with 69.9% credit (debt) and the remaining percentage (100% - 69.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lyka Labs Limited:

  • The MRQ is 0.699. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.699. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.699TTM0.6990.000
TTM0.699YOY0.927-0.229
TTM0.6995Y0.925-0.226
5Y0.92510Y0.869+0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6990.332+0.367
TTM0.6990.334+0.365
YOY0.9270.268+0.659
5Y0.9250.366+0.559
10Y0.8690.390+0.479
1.4.2. Debt to Equity Ratio

Measures if Lyka Labs Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • A Debt to Equity ratio of 232.9% means that company has ₹2.33 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lyka Labs Limited:

  • The MRQ is 2.329. The company is just not able to pay all its debts with equity.
  • The TTM is 2.329. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.329TTM2.3290.000
TTM2.329YOY12.904-10.575
TTM2.3295Y3.813-1.483
5Y3.81310Y4.273-0.461
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3290.381+1.948
TTM2.3290.390+1.939
YOY12.9040.334+12.570
5Y3.8130.434+3.379
10Y4.2730.466+3.807

2. Market Valuation of Lyka Labs Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Lyka Labs Limited generates.

  • Above 15 is considered overpriced but always compare Lyka Labs Limited to the Biotechnology industry mean.
  • A PE ratio of -26.14 means the investor is paying ₹-26.14 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lyka Labs Limited:

  • The EOD is -32.259. Based on the earnings, the company is expensive. -2
  • The MRQ is -26.135. Based on the earnings, the company is expensive. -2
  • The TTM is -26.135. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.259MRQ-26.135-6.124
MRQ-26.135TTM-26.1350.000
TTM-26.135YOY11.520-37.656
TTM-26.1355Y-7.353-18.782
5Y-7.35310Y-4.534-2.819
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-32.259-2.315-29.944
MRQ-26.135-2.560-23.575
TTM-26.135-2.664-23.471
YOY11.520-4.122+15.642
5Y-7.353-6.258-1.095
10Y-4.534-6.108+1.574
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lyka Labs Limited:

  • The EOD is 555.526. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 450.071. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 450.071. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD555.526MRQ450.071+105.455
MRQ450.071TTM450.0710.000
TTM450.071YOY6.246+443.825
TTM450.0715Y96.244+353.827
5Y96.24410Y57.199+39.045
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD555.526-3.067+558.593
MRQ450.071-3.251+453.322
TTM450.071-3.545+453.616
YOY6.246-5.595+11.841
5Y96.244-8.315+104.559
10Y57.199-8.708+65.907
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lyka Labs Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.56 means the investor is paying ₹7.56 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Lyka Labs Limited:

  • The EOD is 9.332. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.561. Based on the equity, the company is overpriced. -1
  • The TTM is 7.561. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.332MRQ7.561+1.771
MRQ7.561TTM7.5610.000
TTM7.561YOY33.210-25.650
TTM7.5615Y7.266+0.294
5Y7.26610Y5.316+1.950
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.3321.905+7.427
MRQ7.5612.111+5.450
TTM7.5612.095+5.466
YOY33.2102.836+30.374
5Y7.2663.443+3.823
10Y5.3163.794+1.522
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lyka Labs Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--9.7259.7250%11.660-17%-0.759+108%-0.728+107%
Book Value Per Share--13.80213.8020%4.077+239%3.912+253%9.439+46%
Current Ratio--1.3561.3560%0.525+158%0.683+99%0.569+138%
Debt To Asset Ratio--0.6990.6990%0.927-25%0.925-24%0.869-20%
Debt To Equity Ratio--2.3292.3290%12.904-82%3.813-39%4.273-45%
Dividend Per Share----0%-0%-0%-0%
Eps---3.993-3.9930%11.753-134%-3.161-21%-2.447-39%
Free Cash Flow Per Share--0.2320.2320%21.678-99%6.406-96%5.217-96%
Free Cash Flow To Equity Per Share---6.309-6.3090%2.586-344%-0.668-89%-2.435-61%
Gross Profit Margin--1.1741.1740%0.929+26%1.224-4%1.238-5%
Intrinsic Value_10Y_max--72.035--------
Intrinsic Value_10Y_min--23.866--------
Intrinsic Value_1Y_max--7.899--------
Intrinsic Value_1Y_min--4.551--------
Intrinsic Value_3Y_max--23.214--------
Intrinsic Value_3Y_min--11.884--------
Intrinsic Value_5Y_max--37.905--------
Intrinsic Value_5Y_min--17.200--------
Market Cap4261992000.000+19%3452941500.0003452941500.0000%4480386000.000-23%2001283200.000+73%1790169000.000+93%
Net Profit Margin---0.141-0.1410%0.212-167%-0.262+85%-0.171+21%
Operating Margin--0.0620.0620%0.464-87%0.065-4%0.041+52%
Operating Ratio--0.9740.9740%0.547+78%0.959+2%1.056-8%
Pb Ratio9.332+19%7.5617.5610%33.210-77%7.266+4%5.316+42%
Pe Ratio-32.259-23%-26.135-26.1350%11.520-327%-7.353-72%-4.534-83%
Price Per Share128.800+19%104.350104.3500%135.400-23%60.480+73%54.100+93%
Price To Free Cash Flow Ratio555.526+19%450.071450.0710%6.246+7106%96.244+368%57.199+687%
Price To Total Gains Ratio13.244+19%10.73010.7300%11.612-8%1.326+709%-21.250+298%
Quick Ratio--1.1361.1360%0.445+156%0.557+104%0.412+176%
Return On Assets---0.087-0.0870%0.210-141%-0.054-37%-0.039-55%
Return On Equity---0.289-0.2890%2.924-110%0.499-158%0.189-253%
Total Gains Per Share--9.7259.7250%11.660-17%-0.759+108%-0.728+107%
Usd Book Value--5480484.0005480484.0000%1618908.000+239%1553193.600+253%3748026.733+46%
Usd Book Value Change Per Share--0.1170.1170%0.140-17%-0.009+108%-0.009+107%
Usd Book Value Per Share--0.1660.1660%0.049+239%0.047+253%0.113+46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.048-0.0480%0.141-134%-0.038-21%-0.029-39%
Usd Free Cash Flow--92064.00092064.0000%8607996.000-99%2543565.600-96%2071519.484-96%
Usd Free Cash Flow Per Share--0.0030.0030%0.260-99%0.077-96%0.063-96%
Usd Free Cash Flow To Equity Per Share---0.076-0.0760%0.031-344%-0.008-89%-0.029-61%
Usd Market Cap51143904.000+19%41435298.00041435298.0000%53764632.000-23%24015398.400+73%21482028.000+93%
Usd Price Per Share1.546+19%1.2521.2520%1.625-23%0.726+73%0.649+93%
Usd Profit---1578288.000-1578288.0000%4679976.000-134%-1277172.000-19%-996217.789-37%
Usd Revenue--11168736.00011168736.0000%22030308.000-49%11121868.800+0%12622613.432-12%
Usd Total Gains Per Share--0.1170.1170%0.140-17%-0.009+108%-0.009+107%
 EOD+5 -3MRQTTM+0 -0YOY+11 -235Y+18 -1610Y+19 -15

3.2. Fundamental Score

Let's check the fundamental score of Lyka Labs Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-32.259
Price to Book Ratio (EOD)Between0-19.332
Net Profit Margin (MRQ)Greater than0-0.141
Operating Margin (MRQ)Greater than00.062
Quick Ratio (MRQ)Greater than11.136
Current Ratio (MRQ)Greater than11.356
Debt to Asset Ratio (MRQ)Less than10.699
Debt to Equity Ratio (MRQ)Less than12.329
Return on Equity (MRQ)Greater than0.15-0.289
Return on Assets (MRQ)Greater than0.05-0.087
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Lyka Labs Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose128.400
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Net Working Capital  -525,071224,241-300,83099,676-201,154-270,390-471,544587,602116,058



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,515,228
Total Liabilities1,058,521
Total Stockholder Equity454,406
 As reported
Total Liabilities 1,058,521
Total Stockholder Equity+ 454,406
Total Assets = 1,515,228

Assets

Total Assets1,515,228
Total Current Assets442,038
Long-term Assets1,073,190
Total Current Assets
Cash And Cash Equivalents 117,108
Short-term Investments 25,590
Net Receivables 202,075
Inventory 69,542
Other Current Assets 27,723
Total Current Assets  (as reported)442,038
Total Current Assets  (calculated)442,038
+/-0
Long-term Assets
Property Plant Equipment 636,688
Goodwill 2,206
Intangible Assets 206,534
Long-term Assets Other 229,968
Long-term Assets  (as reported)1,073,190
Long-term Assets  (calculated)1,075,396
+/- 2,206

Liabilities & Shareholders' Equity

Total Current Liabilities325,980
Long-term Liabilities732,541
Total Stockholder Equity454,406
Total Current Liabilities
Short-term Debt 87,608
Short Long Term Debt 79,163
Accounts payable 94,056
Other Current Liabilities 134,650
Total Current Liabilities  (as reported)325,980
Total Current Liabilities  (calculated)395,477
+/- 69,497
Long-term Liabilities
Long term Debt Total 658,691
Capital Lease Obligations 29,251
Long-term Liabilities  (as reported)732,541
Long-term Liabilities  (calculated)687,942
+/- 44,599
Total Stockholder Equity
Common Stock306,900
Retained Earnings -1,356,577
Accumulated Other Comprehensive Income 270,686
Other Stockholders Equity 1,233,397
Total Stockholder Equity (as reported)454,406
Total Stockholder Equity (calculated)454,406
+/-0
Other
Capital Stock306,900
Cash And Equivalents117,108
Cash and Short Term Investments 142,698
Common Stock Shares Outstanding 28,783
Current Deferred Revenue9,666
Liabilities and Stockholders Equity 1,515,228
Net Debt 629,191
Net Invested Capital 1,171,454
Net Working Capital 116,058
Property Plant and Equipment Gross 636,688
Short Long Term Debt Total 746,299



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312010-03-312009-03-31
> Total Assets 
3,033,481
3,558,349
3,319,420
2,888,995
3,292,670
2,787,634
2,456,041
2,484,352
2,350,896
2,173,711
1,997,894
1,900,121
1,856,144
1,515,228
1,515,2281,856,1441,900,1211,997,8942,173,7112,350,8962,484,3522,456,0412,787,6343,292,6702,888,9953,319,4203,558,3493,033,481
   > Total Current Assets 
1,223,418
1,348,116
1,326,299
1,272,374
1,180,935
1,016,873
597,830
854,033
506,572
347,673
355,425
291,232
521,982
442,038
442,038521,982291,232355,425347,673506,572854,033597,8301,016,8731,180,9351,272,3741,326,2991,348,1161,223,418
       Cash And Cash Equivalents 
71,549
51,398
47,263
47,996
107,100
65,130
55,552
51,219
1,740
-2,826
1,793
2,360
13,466
117,108
117,10813,4662,3601,793-2,8261,74051,21955,55265,130107,10047,99647,26351,39871,549
       Short-term Investments 
0
0
0
0
0
0
0
21,370
14,463
30,058
15,042
4,742
8,110
25,590
25,5908,1104,74215,04230,05814,46321,3700000000
       Net Receivables 
0
0
0
0
701,385
567,014
324,733
297,130
211,199
163,491
262,879
234,672
412,050
202,075
202,075412,050234,672262,879163,491211,199297,130324,733567,014701,3850000
       Inventory 
125,376
140,216
160,783
180,741
158,300
192,457
108,116
132,407
111,969
70,023
67,328
43,062
81,981
69,542
69,54281,98143,06267,32870,023111,969132,407108,116192,457158,300180,741160,783140,216125,376
       Other Current Assets 
1,026,493
1,156,502
1,118,252
1,043,637
915,535
759,286
69,680
670,407
378,400
18,277
8,383
6,396
6,375
27,723
27,7236,3756,3968,38318,277378,400670,40769,680759,286915,5351,043,6371,118,2521,156,5021,026,493
   > Long-term Assets 
1,810,063
2,210,234
1,993,121
1,616,620
2,111,735
1,770,761
0
1,630,320
1,844,324
1,826,038
1,642,469
1,608,889
1,334,162
1,073,190
1,073,1901,334,1621,608,8891,642,4691,826,0381,844,3241,630,32001,770,7612,111,7351,616,6201,993,1212,210,2341,810,063
       Property Plant Equipment 
730,483
1,245,865
1,031,697
999,755
1,035,696
743,819
1,014,214
728,977
940,146
916,860
894,428
839,985
859,711
636,688
636,688859,711839,985894,428916,860940,146728,9771,014,214743,8191,035,696999,7551,031,6971,245,865730,483
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,206
2,2060000000000000
       Long Term Investments 
0
0
0
0
3,011
3,160
3,865
2,612
2,278
108
0
0
0
0
00001082,2782,6123,8653,1603,0110000
       Intangible Assets 
512,995
478,829
423,220
0
806,562
742,851
532,788
580,490
553,144
474,275
434,149
402,868
260,999
206,534
206,534260,999402,868434,149474,275553,144580,490532,788742,851806,5620423,220478,829512,995
       Long-term Assets Other 
566,585
485,539
538,204
616,865
1,076,040
1,026,942
0
885,572
323,696
334,569
205,963
207,229
87,458
229,968
229,96887,458207,229205,963334,569323,696885,57201,026,9421,076,040616,865538,204485,539566,585
> Total Liabilities 
1,789,870
2,133,027
2,116,591
2,191,372
2,732,502
2,321,925
2,009,097
2,063,338
1,768,540
1,716,125
2,149,008
2,151,045
1,721,235
1,058,521
1,058,5211,721,2352,151,0452,149,0081,716,1251,768,5402,063,3382,009,0972,321,9252,732,5022,191,3722,116,5912,133,0271,789,870
   > Total Current Liabilities 
701,347
995,581
844,160
1,472,118
2,080,942
1,945,880
1,627,582
1,663,037
1,676,211
872,744
656,255
492,386
993,526
325,980
325,980993,526492,386656,255872,7441,676,2111,663,0371,627,5821,945,8802,080,9421,472,118844,160995,581701,347
       Short-term Debt 
1,715
7,035
11,357
587,804
662,030
598,513
611,278
889,598
1,100,912
171,396
152,349
110,501
679,517
87,608
87,608679,517110,501152,349171,3961,100,912889,598611,278598,513662,030587,80411,3577,0351,715
       Short Long Term Debt 
0
0
0
0
1,655,094
461,985
340,164
885,615
1,074,819
168,398
160,392
103,653
671,186
79,163
79,163671,186103,653160,392168,3981,074,819885,615340,164461,9851,655,0940000
       Accounts payable 
459,702
713,311
528,703
433,081
632,624
546,357
420,833
7,634
349,566
325,971
248,491
220,877
139,325
94,056
94,056139,325220,877248,491325,971349,5667,634420,833546,357632,624433,081528,703713,311459,702
       Other Current Liabilities 
239,929
275,235
304,100
451,234
786,288
801,010
137,323
765,805
225,733
375,377
9,137
32,911
158,037
134,650
134,650158,03732,9119,137375,377225,733765,805137,323801,010786,288451,234304,100275,235239,929
   > Long-term Liabilities 
1,088,524
1,137,446
1,272,431
719,254
651,561
376,045
0
400,301
92,329
843,381
1,492,753
1,658,659
727,709
732,541
732,541727,7091,658,6591,492,753843,38192,329400,3010376,045651,561719,2541,272,4311,137,4461,088,524
       Long term Debt Total 
0
0
0
0
0
289,217
258,592
357,723
49,316
792,847
1,260,963
1,513,607
624,860
658,691
658,691624,8601,513,6071,260,963792,84749,316357,723258,592289,21700000
       Other Liabilities 
0
0
0
0
71,544
80,307
43,165
58,066
43,013
60,268
211,349
135,754
102,849
0
0102,849135,754211,34960,26843,01358,06643,16580,30771,5440000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
36,641
35,654
30,283
36,841
44,141
57,016
0
057,01644,14136,84130,28335,65436,6410000000
> Total Stockholder Equity
1,223,563
1,402,069
1,185,877
669,509
527,133
430,609
446,944
392,039
529,973
448,143
-143,446
-257,967
133,384
454,406
454,406133,384-257,967-143,446448,143529,973392,039446,944430,609527,133669,5091,185,8771,402,0691,223,563
   Common Stock
226,657
226,657
226,657
226,657
226,657
226,657
220,400
220,400
281,400
281,400
286,900
286,900
286,900
306,900
306,900286,900286,900286,900281,400281,400220,400220,400226,657226,657226,657226,657226,657226,657
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 
-250,482
-282,928
-324,370
-353,894
-399,818
-374,958
0
-432,619
-98,026
-151,306
94,168
95,192
96,547
270,686
270,68696,54795,19294,168-151,306-98,026-432,6190-374,958-399,818-353,894-324,370-282,928-250,482
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
1,247,388
1,458,340
1,283,590
1,250,921
1,295,503
1,223,612
73,132
1,247,991
1,170,234
1,201,747
974,398
974,397
974,397
1,233,397
1,233,397974,397974,397974,3981,201,7471,170,2341,247,99173,1321,223,6121,295,5031,250,9211,283,5901,458,3401,247,388



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue930,728
Cost of Revenue-375,545
Gross Profit555,183555,183
 
Operating Income (+$)
Gross Profit555,183
Operating Expense-531,299
Operating Income57,89423,884
 
Operating Expense (+$)
Research Development14,292
Selling General Administrative28,760
Selling And Marketing Expenses22,823
Operating Expense531,29965,875
 
Net Interest Income (+$)
Interest Income118,703
Interest Expense-118,703
Other Finance Cost-118,703
Net Interest Income-118,703
 
Pretax Income (+$)
Operating Income57,894
Net Interest Income-118,703
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-131,711247,499
EBIT - interestExpense = -60,809
-131,711
-12,821
Interest Expense118,703
Earnings Before Interest and Taxes (EBIT)57,894-13,008
Earnings Before Interest and Taxes (EBITDA)199,367
 
After tax Income (+$)
Income Before Tax-131,711
Tax Provision--187
Net Income From Continuing Ops-131,524-131,524
Net Income-131,524
Net Income Applicable To Common Shares-132,118
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses906,844
Total Other Income/Expenses Net-189,605118,703
 

Technical Analysis of Lyka Labs Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lyka Labs Limited. The general trend of Lyka Labs Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lyka Labs Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lyka Labs Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 143.50 < 144.30 < 152.95.

The bearish price targets are: 114.40 > 106.00 > 105.75.

Tweet this
Lyka Labs Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lyka Labs Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lyka Labs Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lyka Labs Limited.

Lyka Labs Limited Daily Moving Average Convergence/Divergence (MACD) ChartLyka Labs Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lyka Labs Limited. The current adx is .

Lyka Labs Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lyka Labs Limited.

Lyka Labs Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lyka Labs Limited.

Lyka Labs Limited Daily Relative Strength Index (RSI) ChartLyka Labs Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lyka Labs Limited.

Lyka Labs Limited Daily Stochastic Oscillator ChartLyka Labs Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lyka Labs Limited.

Lyka Labs Limited Daily Commodity Channel Index (CCI) ChartLyka Labs Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lyka Labs Limited.

Lyka Labs Limited Daily Chande Momentum Oscillator (CMO) ChartLyka Labs Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lyka Labs Limited.

Lyka Labs Limited Daily Williams %R ChartLyka Labs Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lyka Labs Limited.

Lyka Labs Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lyka Labs Limited.

Lyka Labs Limited Daily Average True Range (ATR) ChartLyka Labs Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lyka Labs Limited.

Lyka Labs Limited Daily On-Balance Volume (OBV) ChartLyka Labs Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lyka Labs Limited.

Lyka Labs Limited Daily Money Flow Index (MFI) ChartLyka Labs Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lyka Labs Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lyka Labs Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lyka Labs Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose128.400
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lyka Labs Limited with someone you think should read this too:
  • Are you bullish or bearish on Lyka Labs Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lyka Labs Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lyka Labs Limited

I send you an email if I find something interesting about Lyka Labs Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Lyka Labs Limited.

Receive notifications about Lyka Labs Limited in your mailbox!